APA (7th ed.) Citation

Tavakkol, A., DuBois, J. C., & Gupta, A. K. (2024). Systemic absorption and safety of topical terbinafine hydrochloride 10% solution (MOB015B): A phase 1 maximal usage trial in patients with moderate-to-severe onychomycosis. Antimicrobial agents and chemotherapy, 68(10), e0068224. https://doi.org/10.1128/aac.00682-24

Chicago Style (17th ed.) Citation

Tavakkol, Amir, Janet C. DuBois, and Aditya K. Gupta. "Systemic Absorption and Safety of Topical Terbinafine Hydrochloride 10% Solution (MOB015B): A Phase 1 Maximal Usage Trial in Patients with Moderate-to-severe Onychomycosis." Antimicrobial Agents and Chemotherapy 68, no. 10 (2024): e0068224. https://doi.org/10.1128/aac.00682-24.

MLA (9th ed.) Citation

Tavakkol, Amir, et al. "Systemic Absorption and Safety of Topical Terbinafine Hydrochloride 10% Solution (MOB015B): A Phase 1 Maximal Usage Trial in Patients with Moderate-to-severe Onychomycosis." Antimicrobial Agents and Chemotherapy, vol. 68, no. 10, 2024, p. e0068224, https://doi.org/10.1128/aac.00682-24.